Keywords: texas, biotechnology, gets, endothelin, antagonist, patent, been

Texas Biotechnology gets endothelin antagonist patent

Article | 18 December 1995

Print This

- Texas Biotechnology has been awarded a US patent, No 5,464,853, on a series of compounds which act as antagonists at endothelin ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in